Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Meunier

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Blood|October 7, 2020
A wave of bipotent T/ILC-restricted progenitors shapes the embryonic thymus microenvironment in a time-dependent mannerRamy Elsaid, Sylvain Meunier, Odile Burlen-Defranoux, et al.
Journal for Immunotherapy of Cancer|November 19, 2024
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustionAnais Debesset, Caroline Pilon, Sylvain Meunier, et al.
Cancers|September 9, 2022
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer ImmunosuppressionMatteo Ponzo, Anais Debesset, Mélissande Cossutta, et al.
Cancers|December 23, 2022
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265Matteo Ponzo, Anais Debesset, Mélissande Cossutta, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Blood|October 7, 2020
A wave of bipotent T/ILC-restricted progenitors shapes the embryonic thymus microenvironment in a time-dependent mannerRamy Elsaid, Sylvain Meunier, Odile Burlen-Defranoux, et al.
Journal for Immunotherapy of Cancer|November 19, 2024
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustionAnais Debesset, Caroline Pilon, Sylvain Meunier, et al.
Cancers|September 9, 2022
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer ImmunosuppressionMatteo Ponzo, Anais Debesset, Mélissande Cossutta, et al.
Cancers|December 23, 2022
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. <i>Cancers</i> 2022<i>, 14</i>, 4265Matteo Ponzo, Anais Debesset, Mélissande Cossutta, et al.
Pageof 3